These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23581641)

  • 41. A phosphorylation site in Bruton's tyrosine kinase selectively regulates B cell calcium signaling efficiency by altering phospholipase C-gamma activation.
    Guo S; Ferl GZ; Deora R; Riedinger M; Yin S; Kerwin JL; Loo JA; Witte ON
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14180-5. PubMed ID: 15375214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amplification of IL-21 signalling pathway through Bruton's tyrosine kinase in human B cell activation.
    Wang SP; Iwata S; Nakayamada S; Niiro H; Jabbarzadeh-Tabrizi S; Kondo M; Kubo S; Yoshikawa M; Tanaka Y
    Rheumatology (Oxford); 2015 Aug; 54(8):1488-97. PubMed ID: 25724205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of nine novel mutations in the Bruton's tyrosine kinase gene in X-linked agammaglobulinaemia patients.
    Orlandi P; Ritis K; Moschese V; Angelini F; Arvanitidis K; Speletas M; Sideras P; Plebani A; Rossi P
    Hum Mutat; 2000 Jan; 15(1):117. PubMed ID: 10612838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural mechanism for Bruton's tyrosine kinase activation at the cell membrane.
    Wang Q; Pechersky Y; Sagawa S; Pan AC; Shaw DE
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9390-9399. PubMed ID: 31019091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel dual inhibitor of microtubule and Bruton's tyrosine kinase inhibits survival of multiple myeloma and osteoclastogenesis.
    Pandey MK; Gowda K; Sung SS; Abraham T; Budak-Alpdogan T; Talamo G; Dovat S; Amin S
    Exp Hematol; 2017 Sep; 53():31-42. PubMed ID: 28647392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation.
    Fluckiger AC; Li Z; Kato RM; Wahl MI; Ochs HD; Longnecker R; Kinet JP; Witte ON; Scharenberg AM; Rawlings DJ
    EMBO J; 1998 Apr; 17(7):1973-85. PubMed ID: 9524120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genotype-phenotype correlation in Bruton's tyrosine kinase deficiency.
    Teimourian S; Nasseri S; Pouladi N; Yeganeh M; Aghamohammadi A
    J Pediatr Hematol Oncol; 2008 Sep; 30(9):679-83. PubMed ID: 18776760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Btk subfamily of cytoplasmic tyrosine kinases: structure, regulation and function.
    Rawlings DJ; Witte ON
    Semin Immunol; 1995 Aug; 7(4):237-46. PubMed ID: 8520028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor alpha production.
    Horwood NJ; Mahon T; McDaid JP; Campbell J; Mano H; Brennan FM; Webster D; Foxwell BM
    J Exp Med; 2003 Jun; 197(12):1603-11. PubMed ID: 12810683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bruton's tyrosine kinase is activated upon CD40 stimulation in human B lymphocytes.
    Brunner C; Avots A; Kreth HW; Serfling E; Schuster V
    Immunobiology; 2002 Oct; 206(4):432-40. PubMed ID: 12437073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Production of monoclonal antibodies to Bruton's tyrosine kinase.
    Stewart DM; Kurman CC; Nelson DL
    Hybridoma; 1995 Jun; 14(3):243-6. PubMed ID: 7590786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bruton's tyrosine kinase as a new therapeutic target.
    Uckun FM; Tibbles HE; Vassilev AO
    Anticancer Agents Med Chem; 2007 Nov; 7(6):624-32. PubMed ID: 18045057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined pharmacophore, virtual screening and molecular dynamics studies to identify Bruton's tyrosine kinase inhibitors.
    Sakthivel S; Habeeb SKM
    J Biomol Struct Dyn; 2018 Dec; 36(16):4320-4337. PubMed ID: 29293382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of the tec kinase Bruton's tyrosine kinase (Btk) in leukocyte recruitment.
    Block H; Zarbock A
    Int Rev Immunol; 2012 Apr; 31(2):104-18. PubMed ID: 22449072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel Bruton's tyrosine kinase gene (BTK) invariant splice site mutation in a Malaysian family with X-linked agammaglobulinemia.
    Chear CT; Gill HK; Ramly NH; Dhaliwal JS; Bujang N; Ripen AM; Mohamad SB
    Asian Pac J Allergy Immunol; 2013 Dec; 31(4):320-4. PubMed ID: 24383975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NF-kappaB regulates the transcription of protein tyrosine kinase Tec.
    Yu L; Simonson OE; Mohamed AJ; Smith CI
    FEBS J; 2009 Nov; 276(22):6714-24. PubMed ID: 19843184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bruton's tyrosine kinase is not essential for Bcr-Abl-mediated transformation of lymphoid or myeloid cells.
    MacPartlin M; Smith AM; Druker BJ; Honigberg LA; Deininger MW
    Leukemia; 2008 Jul; 22(7):1354-60. PubMed ID: 18548107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of novel Bruton's tyrosine kinase gene mutations in Central European patients with agammaglobulinemia.
    Kristufek D; Aspalter RM; Eibl MM; Wolf HM
    Mol Immunol; 2007 Mar; 44(7):1639-43. PubMed ID: 17045652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ABBV-105, a selective and irreversible inhibitor of Bruton's tyrosine kinase, is efficacious in multiple preclinical models of inflammation.
    Goess C; Harris CM; Murdock S; McCarthy RW; Sampson E; Twomey R; Mathieu S; Mario R; Perham M; Goedken ER; Long AJ
    Mod Rheumatol; 2019 May; 29(3):510-522. PubMed ID: 29862859
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and characterization of a molecule, BAM11, that associates with the pleckstrin homology domain of mouse Btk.
    Kikuchi Y; Hirano M; Seto M; Takatsu K
    Int Immunol; 2000 Oct; 12(10):1397-408. PubMed ID: 11007757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.